The enigma of fulminant viral hepatitis
Arie J. Zuckerman,
Corresponding Author
Arie J. Zuckerman
WHO Collaborating Centre for Reference and Research on Viral Hepatitis Department of Medical Microbiology London School of Hygiene and Tropical Medicine University of London London WClE 7HT, England
Arie J. Zuckerman, M.D., F.R.C.P., Department of Medical Microbiology, London School of Hygiene and Tropical Medicine, Keppel Street, London WClE 7HT, England.===
Search for more papers by this author
Arie J. Zuckerman,
Corresponding Author
Arie J. Zuckerman
WHO Collaborating Centre for Reference and Research on Viral Hepatitis Department of Medical Microbiology London School of Hygiene and Tropical Medicine University of London London WClE 7HT, England
Arie J. Zuckerman, M.D., F.R.C.P., Department of Medical Microbiology, London School of Hygiene and Tropical Medicine, Keppel Street, London WClE 7HT, England.===
Search for more papers by this author
First published: May‐June 1984
No abstract is available for this article.
References
- 1
Trepo CG,
Robert D,
Montin J, et al.
Hepatitis B antigen (HBsAg) and/or or antibodies (anti-HBs, anti-HBc) in fulminant hepatitis: pathogenic significance and prognostic significance.
Gut
1976;
17:
10–18.
- 2
Woolfe IL,
Sheikh N El,
Cullens H, et al.
Enhanced anti-HBs production in the pathogenesis of fulminant viral hepatitis.
Br Med J,
1976;
17:
10–18.
- 3
Gimson AES,
Tedder RS,
White YS, et al.
Serological markers in fulminant hepatitis B.
Gut
1983;
24:
615–617.
- 4
Canalese J,
Wyke RJ,
Vergani D, et al.
Circulating immune complexes in patients with fulminant hepatic failure.
Gut
1981;
22:
845–848.
- 5
Brechot C,
Bernuau J,
Thiers V, et al.
Multiplication of hepatitis B virus in fulminant hepatitis B.
Br Med J
1984;
288:
270–271.
- 6
Papaevangelou G,
Tassopoulous N,
Roumeliotou-Karayannis A, et al.
Etiology of fulminant viral hepatitis in Greece.
Hepatology
1984;
4:
369–372.
- 7
Shimizu M,
Ohyama M,
Takahashi Y, et al.
Immunoglobulin M antibody against hepatitis B core antigen for the diagnosis of fulminant type B hepatitis.
Gastroenterology
1983;
84:
604–610.
- 8
Smedile A,
Farci P,
Verme G, et al.
Influence of delta infection on severity of hepatitis B.
Lancet
1982;
2:
945–947.
- 9
Viral Hepatitis.
Report on a WHO Round-Table discussion.
Bull Wld Hlth Org
1982;
60:
661–691
(based on a report submitted for publication by Hadler SC, de Monzon M, Ponzetto A, et al.).
- 10
Tabor E,
Ponzetto A,
Gerin JL, et al.
Does delta agent contribute to fulminant hepatitis?
Lancet
1983;
1:
765–766.
